Asia FX Slides as Dollar Surges Amid U.S.-Iran Tensions and Inflation Fears 
Colombia and Ecuador Trade War Escalates With Retaliatory Tariffs 
Bank of Korea Governor Nominee Warns of Action if Korean Won Weakens Further 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Japan Consumer Confidence Drops Sharply Amid Rising Fuel Costs and Middle East Tensions 
Bank of America Maintains Forecast for Two Fed Rate Cuts in 2026 Despite Inflation Risks 
Oil Prices Rise Amid Strait of Hormuz Tensions and U.S.-Iran Talks 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Iran War Fallout: How Sri Lanka, Pakistan, and Egypt Are Struggling With Rising Energy Costs 
U.S. Blockades Strait of Hormuz as Oil Prices Surge Past $100 
Italy's Bond Market Under Pressure as Middle East Conflict Exposes Economic Fragility 
Asian Stocks Rally on Ceasefire Hopes and Bargain Buying 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
LG, Samsung, Hyundai, three of the leading companies in South Korea, just ditched the Moderna COVID-19 vaccine as it is taking time for them to arrive. The firms originally announced that their employees are set to be inoculated with the Massachusetts-based biotechnology company’s vaccine, but as it has been difficult to procure enough vials, it was replaced.
Pfizer COVID-19 vaccine to replace Moderna
As per The Korea Times, S. Korea is actually struggling to obtain a sufficient supply of the Moderna shots. Because of this, the government made the decision to just change the brand of COVID-19 vaccines to Pfizer. These will be used for workers employed in big manufacturing companies, including Hyundai Motor, LG Group, and Samsung.
With the change of plans, it was reported that officials of large firms were notified by the Korea Disease Control and Prevention Agency (KDCA) about the replacement of Moderna vaccines for their employees. On Tuesday, July 20, companies said they were informed that Pfizer shots will instead be delivered to them.
It was only last month when the S. Korean government shared that it will be alloting Moderna vaccines to individuals working in the country’s leading business fields such as automotive, technology, and semiconductor. The officials are somehow prioritizing them due to concerns that the national economy will be gravely affected if the coronavirus spreads in these businesses.
"The Moderna vaccine supply, scheduled for the third week of July, has been postponed to the last week of July, due to quality inspections and delivery issues," KDCA director Jeong Eun Kyeong said in a statement on Tuesday. "We plan to discuss with the Ministry of Employment and Labor and companies to confirm the shift to the Pfizer vaccine."
Reason for the change of vaccine brand
It was mentioned earlier that the government has been having a hard time securing the Moderna vaccines, so the officials changed it to Pfizer. In related news, Yonhap News Agency stated that companies including LG and Samsung are replacing the shot because Moderna’s arrival schedule has been delayed.
It was added that the employees of the said firms are set to receive their first dose of the COVID-19 vaccine starting on July 27. "Our vaccination program will go on as scheduled but with a change of vaccine," an official from Samsung said.
